BioCentury
ARTICLE | Clinical News

Immunomedics regulatory update

April 15, 1996 7:00 AM UTC

The FDA issued an approvable letter for IMMU's CEA-Scan, its in vivo diagnostic imaging product for colorectal cancer. ...